コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 aneous transluminal coronary angioplasty and coronary artery bypass graft surgery).
2 F to improve outcomes in patients undergoing coronary artery bypass graft surgery.
3 ervational study of 4224 patients undergoing coronary artery bypass graft surgery.
4 created to predict long-term mortality after coronary artery bypass graft surgery.
5 roxide (O(2)(.-)) in 492 patients undergoing coronary artery bypass graft surgery.
6 risk factors for early SVG thrombosis after coronary artery bypass graft surgery.
7 ing 5-MTHF levels in 218 patients undergoing coronary artery bypass graft surgery.
8 tic (n = 11) patients undergoing nonemergent coronary artery bypass graft surgery.
9 either percutaneous coronary intervention or coronary artery bypass graft surgery.
10 n occurred in 191 (9.1%) patients undergoing coronary artery bypass graft surgery.
11 stratification of whites undergoing primary coronary artery bypass graft surgery.
12 farction and 31.0% of patients who underwent coronary artery bypass graft surgery.
13 edictors of PMI in whites undergoing primary coronary artery bypass graft surgery.
14 dial infarction (PMI) in patients undergoing coronary artery bypass graft surgery.
15 sustaining a myocardial infarction following coronary artery bypass graft surgery.
16 oduct transfusions during and after off-pump coronary artery bypass graft surgery.
17 with propofol for short-term sedation after coronary artery bypass graft surgery.
18 tilation is a significant complication after coronary artery bypass graft surgery.
19 onary intervention, or previous multi-vessel coronary artery bypass graft surgery.
20 ed blood samples from 39 patients undergoing coronary artery bypass graft surgery.
21 l ventilation is a common complication after coronary artery bypass graft surgery.
22 function is a common cause of bleeding after coronary artery bypass graft surgery.
23 comitant reduction in the need for emergency coronary artery bypass graft surgery.
24 cell and cryoprecipitate transfusions after coronary artery bypass graft surgery.
25 units (2.4 vs. 1.2, p =.04) transfused after coronary artery bypass graft surgery.
26 clopidogrel on bleeding complications after coronary artery bypass graft surgery.
27 s, but were less likely to have prior PCI or coronary artery bypass graft surgery.
28 ear 207 men and 102 women, who had undergone coronary artery bypass graft surgery.
29 severe sepsis and septic shock, and low-risk coronary artery bypass graft surgery.
30 baseline ST segment depression and previous coronary artery bypass graft surgery.
31 ption as sole therapy or in combination with coronary artery bypass graft surgery.
32 ntions in acute coronary syndromes and after coronary artery bypass graft surgery.
33 Is; and 19 (1.6%) more sites were performing coronary artery bypass graft surgery.
34 ison with IV propofol for patient undergoing coronary artery bypass graft surgery.
35 Sixty-two patients (77%) had concomitant coronary artery bypass graft surgery.
36 control patients in sinus rhythm undergoing coronary artery bypass graft surgery.
37 18.5%) were repeat operations after previous coronary artery bypass graft surgery.
38 n 35.4% of the group, and 16.9% had previous coronary artery bypass graft surgery.
39 aphy for assessing graft stenoses late after coronary artery bypass graft surgery.
40 onsortium (BARC) major bleeding unrelated to coronary artery bypass graft surgery.
41 risk of death and stroke when compared with coronary artery bypass graft surgery.
42 t greatest short-term risk of mortality with coronary artery bypass graft surgery.
43 isease, 218 (22%) were deemed ineligible for coronary artery bypass graft surgery.
44 llitus, and renal failure), and a history of coronary artery bypass graft surgery.
45 t patients (99%) were men, and 30% had prior coronary artery bypass graft surgery.
46 ump surgery compared with angiography-guided coronary artery bypass graft surgery.
47 on, yet little is known about candidates for coronary artery bypass graft surgery.
48 ic syndrome, in sinus rhythm, and undergoing coronary artery bypass graft surgery.
49 tery disease limit the long-term efficacy of coronary artery bypass graft surgery.
50 therapy, percutaneous intervention, and redo coronary artery bypass graft surgery.
51 oor in-hospital and long-term outcomes after coronary artery bypass graft surgery.
52 The study included 677 patients undergoing coronary artery bypass graft surgery.
53 nce of percutaneous coronary angioplasty and coronary artery bypass graft surgery.
54 t (n = 14) have diabetes and were undergoing coronary artery bypass grafting surgery.
55 l centers among patients undergoing isolated coronary artery bypass grafting surgery.
56 contributor to morbidity and mortality after coronary artery bypass grafting surgery.
57 us coronary angioplasty (-0.717; -0.787) and coronary artery bypass graft surgery (-0.541; -0.618).
58 s driven by BARC major bleeding unrelated to coronary artery bypass graft surgery (1.6% vs 2.3%, RR 0
59 mained at higher risk for repeat procedures (coronary artery bypass graft surgery: 10.7% versus 6.8%,
60 gina (42.9% vs. 56.5%, p < 0.01) or previous coronary artery bypass graft surgery (18.8% vs. 24.5%, p
61 nary artery disease (64.4% vs. 83.7%), prior coronary artery bypass graft surgery (19.8% vs. 61.2%),
62 h, Q-wave myocardial infarction, or emergent coronary artery bypass graft surgery [2.8% versus 3.3%])
63 4%; AOR, 2.49 [2.28 to 2.72]; P < .001), and coronary artery bypass graft surgery (3.7% vs 1.3%; AOR,
65 ercent vs. 4.6 percent, P < or = 0.001); and coronary-artery bypass graft surgery (35.0 percent vs. 1
67 e total cohort (39%, P<0.0001) and both post-coronary artery bypass graft surgery (38%, P=0.048) and
68 cularizations (7.5%) occurred, including 140 coronary artery bypass graft surgeries (4.1%) and 114 pe
70 ed with 809 with WCDs (90-day mortality post-coronary artery bypass graft surgery 7% versus 3%, P=0.0
71 for target vessel or target lesion failure (coronary artery bypass graft surgery: 8.9% versus 3.9%,
72 female and have three-vessel disease, prior coronary artery bypass graft surgery, a history of hyper
73 significantly higher in patients undergoing coronary artery bypass graft surgery after 4 wk of consu
74 ent predictor of PMI in whites after primary coronary artery bypass graft surgery after adjustment fo
75 assessed patient-perceived satisfaction with coronary artery bypass graft surgery after administratio
76 uccessful laboratory outcome, and 1 required coronary artery bypass graft surgery after failed rescue
77 However, there is paucity of data comparing coronary artery bypass graft surgery against newer gener
78 rly revascularization, of whom 264 underwent coronary artery bypass graft surgery and 487 underwent p
79 Association (AHA) 2004 Guideline Update for Coronary Artery Bypass Graft Surgery and actual clinical
81 rately predicted the risk of mortality after coronary artery bypass graft surgery and can be used for
82 The frequencies of in-hospital Q-wave MI, coronary artery bypass graft surgery and death were 0.4%
83 nd CSCs were isolated from vein leftovers of coronary artery bypass graft surgery and discarded atria
84 tudied data from 1829 patients who underwent coronary artery bypass graft surgery and had an angiogra
85 among Medicare beneficiaries undergoing any coronary artery bypass graft surgery and higher observed
87 ontribute to adverse clinical outcomes after coronary artery bypass graft surgery and myocardial infa
88 h diabetes mellitus and multivessel disease, coronary artery bypass graft surgery and percutaneous co
89 isk and repeated coronary revascularization (coronary artery bypass graft surgery and percutaneous tr
91 educe the rates of abrupt closure, emergency coronary artery bypass graft surgery and restenosis, but
92 s recovering from a myocardial infarction or coronary artery bypass graft surgery and those with seve
94 s focused on the use of drug eluting stents, coronary-artery bypass graft surgery and anti-thrombosis
95 gastrectomy, pancreatectomy, thyroidectomy, coronary artery bypass graft surgery, and carotid endart
96 rtality in abdominal aortic aneurysm repair, coronary artery bypass graft surgery, and craniotomy, an
97 uitable collaterals, no smoking, no previous coronary artery bypass graft surgery, and left anterior
99 y coronary angiography 12 to 18 months after coronary artery bypass graft surgery, and subsequent cli
102 (with percutaneous coronary intervention or coronary artery bypass graft surgery as appropriate) plu
103 hown that adult patients undergoing elective coronary artery bypass graft surgery at a single tertiar
104 analyzed 20 896 patients undergoing isolated coronary artery bypass grafting surgery at 33 medical ce
105 relative to the pool of patients undergoing coronary artery bypass grafting surgery at the remaining
106 ay affect the outcome of patients undergoing coronary artery bypass graft surgery beneficially by pro
107 terval [CI], 1.04-1.04; P<0.001); history of coronary artery bypass graft surgery (beta=1.32; CI, 1.2
108 Medicare data to compare change in rates of coronary artery bypass graft surgery between 2002 to 200
109 tion, percutaneous coronary intervention, or coronary artery bypass graft surgery between January 200
110 f 1572 patients undergoing isolated off-pump coronary artery bypass graft surgery between January 200
111 AVR) or with (48.9%; AVR + CABG) concomitant coronary artery bypass graft surgery between November 10
112 Vein graft failure (VGF) is common after coronary artery bypass graft surgery, but its relationsh
113 harvesting (EVH) should be standard care in coronary artery bypass graft surgery, but vein quality a
114 rs of 30-day all-cause readmission following coronary artery bypass grafting surgery by using nationa
115 ocardial infarction (MI) (2.3% vs. 3.0%) and coronary artery bypass graft surgery (CABG) (1.3% vs. 1.
116 al coronary angioplasty (PTCA) (n = 834) and coronary artery bypass graft surgery (CABG) (n = 1805) i
117 nsluminal coronary angioplasty (PTCA) or for coronary artery bypass graft surgery (CABG) 40 vs. 46%,
118 onary intervention (PCI) with survival after coronary artery bypass graft surgery (CABG) among diabet
119 ng characteristics of patients with previous coronary artery bypass graft surgery (CABG) and acute my
120 iation have issued guidelines for the use of coronary artery bypass graft surgery (CABG) and percutan
121 short- and long-term survival and subsequent coronary artery bypass graft surgery (CABG) and percutan
122 e if elevated cardiac serum biomarkers after coronary artery bypass graft surgery (CABG) are associat
123 Percutaneous coronary intervention (PCI) and coronary artery bypass graft surgery (CABG) are being ap
124 ignificant long-term survival advantage with coronary artery bypass graft surgery (CABG) compared wit
126 d the differences in specific causes of post-coronary artery bypass graft surgery (CABG) deaths in th
128 h (SCD) in patients with heart failure after coronary artery bypass graft surgery (CABG) has not been
130 s, percutaneous intervention (PI) in 30% and coronary artery bypass graft surgery (CABG) in 24%.
131 percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG) in physician
132 al outcomes of elderly patients treated with coronary artery bypass graft surgery (CABG) in the Unite
133 New-onset atrial fibrillation (AF) after coronary artery bypass graft surgery (CABG) is associate
137 on to estimate the likelihood of in-hospital coronary artery bypass graft surgery (CABG) might be use
138 dies have suggested that public reporting of coronary artery bypass graft surgery (CABG) mortality mi
139 y artery occlusion during minimally invasive coronary artery bypass graft surgery (CABG) on hemodynam
140 es of diabetic patients who underwent repeat coronary artery bypass graft surgery (CABG) or percutane
142 fect of preoperative beta-blocker therapy on coronary artery bypass graft surgery (CABG) outcomes has
143 te the effect of preoperative clopidogrel on coronary artery bypass graft surgery (CABG) outcomes.
146 l coronary angioplasty (PTCA) with predicted coronary artery bypass graft surgery (CABG) short-term a
147 se study included 389 patients; 312 had only coronary artery bypass graft surgery (CABG) surgery, 37
149 n/flutter (AF) is a frequent complication of coronary artery bypass graft surgery (CABG) that leads t
150 se in Individuals With Diabetes) trial found coronary artery bypass graft surgery (CABG) was associat
151 vessel or left main coronary artery disease, coronary artery bypass graft surgery (CABG) was associat
154 meta-analysis of randomized trials comparing coronary artery bypass graft surgery (CABG) with percuta
155 ution of the onset of stroke occurring after coronary artery bypass graft surgery (CABG) without card
156 VF are rare but serious complications after coronary artery bypass graft surgery (CABG), and their e
159 transluminal coronary angioplasty (PTCA) or coronary artery bypass graft surgery (CABG), should thes
160 l therapy is low among patients treated with coronary artery bypass graft surgery (CABG), we evaluate
181 inical complications (myocardial infarction, coronary artery bypass graft surgery [CABG] or acute ves
182 ) patients requiring cardiopulmonary bypass (coronary artery bypass graft surgery [CABG]) in a broad
183 are contemporary surgical revascularization (coronary artery bypass graft surgery [CABG]) versus TAXU
184 (percutaneous coronary intervention [PCI] vs coronary artery bypass graft surgery [CABG]) were prospe
185 transluminal coronary angioplasty [PTCA] or coronary artery bypass graft surgery [CABG]), the primar
186 ns alone, percutaneous revascularization, or coronary artery bypass graft surgery--can be selected.
187 ger in the subgroup of patients intended for coronary artery bypass graft surgery compared with the s
188 lue of 93% to 99% for excluding various post-coronary artery bypass graft surgery complications.
189 phically confirmed angina (1.91; 1.59-2.29), coronary artery bypass graft surgery/coronary angioplast
190 TO were treated medically, and 25% underwent coronary artery bypass graft surgery (CTO bypassed in 88
191 L after AMI, including younger age, previous coronary artery bypass graft surgery, depressive symptom
193 -hospital outcomes included death, emergency coronary artery bypass graft surgery (eCABG), non-emerge
194 ival difference between off-pump and on-pump coronary artery bypass graft surgery for follow-up longe
195 of a deleterious effect of P4P on access to coronary artery bypass graft surgery for high-risk patie
196 ayo Clinic patients who had isolated primary coronary artery bypass graft surgery for multivessel cor
197 oracic Surgeons database undergoing isolated coronary artery bypass graft surgery from 2004 to 2006.
199 nsin-converting enzyme inhibitors (ACEIs) in coronary artery bypass graft surgery has been erratic an
200 trend of acute renal failure associated with coronary artery bypass graft surgery has significantly i
201 registry 627 consecutive patients treated by coronary artery bypass graft surgery having at least 1 a
202 iac rehabilitation (CR) is recommended after coronary artery bypass graft surgery; however, the conse
203 onary artery disease improves survival after coronary artery bypass graft surgery; however, the survi
204 The MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery II Trial, a phase 3
207 were characterized 3 days and 6 months after coronary artery bypass graft surgery in 229 subjects rec
208 izations for acute myocardial infarctions or coronary artery bypass graft surgery in 267,427 fee-for-
209 was measured during the first 24 hours after coronary artery bypass graft surgery in 847 consecutive
210 dentify 8597 patients who underwent isolated coronary artery bypass graft surgery in July through Dec
211 without acute coronary syndromes or previous coronary artery bypass graft surgery in periods before (
212 ocedures that were misclassified as isolated coronary artery bypass grafting surgery in the administr
213 e subset of high-risk patients who underwent coronary artery bypass graft surgery, in whom both prere
214 Both percutaneous coronary intervention and coronary artery bypass graft surgery independently contr
215 ests that withdrawal of ACEI treatment after coronary artery bypass graft surgery is associated with
217 nosis of acute renal failure associated with coronary artery bypass graft surgery is increasing in th
218 -term mortality between on-pump and off-pump coronary artery bypass graft surgery is not statisticall
221 al Health Insurance Database associated with coronary artery bypass graft surgery, myocardial infarct
222 g complications or who underwent in-hospital coronary artery bypass graft surgery (N = 2,258,711 visi
223 , 0.61; 95% confidence interval, 0.55-0.67), coronary artery bypass graft surgery (n=1077; hazard rat
224 found that high body mass index, history of coronary artery bypass graft surgery, number of treated
226 was death, myocardial infarction, emergency coronary artery bypass graft surgery or abrupt vessel cl
227 substantially after adjustment for hospital coronary artery bypass graft surgery or cardiac catheter
228 by the intended method of revascularization, coronary artery bypass graft surgery or percutaneous cor
229 s predict in-hospital mortality after either coronary artery bypass graft surgery or percutaneous cor
230 artery revascularization by procedure type (coronary artery bypass graft surgery or percutaneous cor
231 3.65) and the observed-to-expected ratio for coronary artery bypass graft surgery or percutaneous cor
232 had diabetes mellitus and underwent isolated coronary artery bypass graft surgery or percutaneous cor
233 oing a coronary revascularization procedure: coronary artery bypass graft surgery or percutaneous cor
234 atients with angina who are not suitable for coronary artery bypass graft surgery or percutaneous tra
236 f a MultiLink stent without death, emergency coronary artery bypass graft surgery or Q wave myocardia
237 vascularization with coronary angioplasty or coronary artery bypass graft surgery or were treated wit
238 icular, the low likelihood of ACEI/ARB after coronary artery bypass grafting surgery or in patients w
239 ; 95% CI 0.89 to 0.95), and those undergoing coronary artery bypass graft surgery (OR 0.58; 95% CI 0.
241 ve myocardial infarction, emergent or urgent coronary artery bypass graft surgery, or cerebrovascular
242 derwent an abdominal aortic aneurysm repair, coronary artery bypass graft surgery, or craniotomy.
243 a composite of all-cause death, MI, emergent coronary artery bypass graft surgery, or target lesion r
244 n in bronchoalveolar lavage fluid rose after coronary artery bypass graft surgery (p < 0.05), but the
245 ed associated with lower mortality (58% post-coronary artery bypass graft surgery, P=0.002; 67% post-
246 retrospective analysis of 47 984 consecutive coronary artery bypass grafting surgeries performed from
248 ntly more complex, both clinically (previous coronary artery bypass graft surgery prevalence, 48% ver
249 ut lower rates of multivessel disease, prior coronary artery bypass graft surgery, prior MI, and smok
251 lic reporting on risk-adjusted mortality for coronary artery bypass graft surgery, public reporting o
252 e end points (in-hospital death, in-hospital coronary artery bypass graft surgery, Q wave myocardial
253 ation between coronary angiography rates and coronary artery bypass graft surgery rates (R(2)=0.41) w
257 artery (RA) can improve clinical outcomes in coronary artery bypass graft surgery remains unclear.
258 spital percutaneous coronary intervention or coronary artery bypass graft surgery, respectively.
260 mpt coronary revascularization among the 381 coronary artery bypass graft surgery-selected patients i
261 ischemic heart disease, a strategy of prompt coronary artery bypass graft surgery significantly reduc
262 death, angiogram-confirmed angina pectoris, coronary artery bypass graft surgery, stents, and angiop
263 clinical-angiographic risk groups within the coronary artery bypass graft surgery stratum, or in any
265 botic events (myocardial infarction, angina, coronary artery bypass graft surgery, stroke, claudicati
268 enal failure remains a major complication of coronary artery bypass graft surgery that is strongly as
269 nts with no acute coronary syndrome/no prior coronary artery bypass graft surgery that were rated as
271 R and compared outcomes of TMR combined with coronary artery bypass graft surgery (TMR + CABG) versus
272 nd mortality in patients undergoing off-pump coronary artery bypass graft surgery using a large patie
273 38 patients undergoing nonemergent, isolated coronary artery bypass grafting surgery using cardiopulm
274 There was a 27.4% disparity in isolated coronary artery bypass grafting surgery volume (4440 cli
278 nsfection IV) analysis reported that EVH for coronary artery bypass graft surgery was associated with
284 tion, and major bleeding not associated with coronary artery bypass graft surgery were also increased
287 r = 65 years old (p = 0.02); angioplasty and coronary artery bypass graft surgery were performed less
288 42 statin-naive patients undergoing elective coronary artery bypass graft surgery were randomized to
289 ysmal atrial fibrillation and indication for coronary artery bypass graft surgery were randomized to
292 taneous transluminal coronary angioplasty or coronary artery bypass graft surgery were similar for wo
293 who underwent cardiac interventions, such as coronary artery bypass graft surgery, were also included
294 There is clear evidence that patients having coronary artery bypass graft surgeries with an internal
295 acheally intubated patients before and after coronary artery bypass graft surgery with cardiopulmonar
296 y artery disease undergoing primary elective coronary artery bypass graft surgery with cardiopulmonar
298 id not improve myocardial stunning following coronary artery bypass graft surgery with cardiopulmonar
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。